Trial Profile
EFFECT OF BEVACIZUMAB SUBCONJUNCTIVAL INJECTIONS ON CORNEAL NEWVESSELS INTERET DES INJECTIONS SOUS-CONJONCTIVALES DE BEVACIZUMAB COMME TRAITEMENT DES NEOVAISSEAUX CORNEENS
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Oct 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Corneal neovascularisation
- Focus Therapeutic Use
- Acronyms BECONNEC
- 01 Dec 2015 New trial record